YLY-78224-41679
3 vaccinations
13 coded responses
43 check-ins
13 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 980 / WA
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Registered in v-safe
-
2021-04-07
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-07
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Itching · Joint pains, Fatigue or tirednessAdult check-in
- 2021-04-12
- 2021-04-13
- 2021-04-14
-
2021-04-21
Survey response — day 14, dose 1MedDRA: Condition aggravated, Eczema, Impaired work ability, Pre-existing disease, Sensitivity to weather change — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Worse symptoms for spoldyloarthritis, fibromyalgia, eczema triggering use of FMLA for 2 days. Suspect related to weather/pressure changes rather than vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-28
-
2021-05-05
Survey response — day 28, single doseMedDRA: Arthralgia, Condition aggravated, Fatigue, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Related to chronic conditions - spondyloarthritis and fibromyalgia - compounded with work stress. High joint pain and fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-12
-
2021-05-19
Survey response — day 42, single doseMedDRA: Pre-existing disease, Stress at work — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Related to chronic conditions (spondyloarthritis, fibromyalgia) and work stress, not related to vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-07
- 2021-10-06
-
2021-11-24
Dose 2 — Moderna
-
2021-11-24
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Good · Fatigue or tirednessFree text: Slight lightheadedness not reaching the point of dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-11-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-11-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · Chills, Joint pains, Fatigue or tirednessAdult check-in
-
2021-11-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-30
-
2021-12-01
Health check-in — day 7, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-08
Survey response — day 14, dose 2MedDRA: Lip infection, Rhinorrhoea — Feeling: GoodFree text: Infection on upper lip related to runny nose, have scheduled appointment.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-15
Survey response — day 21, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fibromyalgia and spondyloarthritis flareupMedDRA releases: 2024-11 · check-in free text available
-
2021-12-22
Survey response — day 28, dose 2MedDRA: Impetigo, Onycholysis, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Impetigo infectionon upper lip, oncycholysis in 3 toenails. I am immunosuppressed with a history of thyroid issues so it is likely just a result of these preexisting conditions.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-29
Survey response — day 35, dose 2MedDRA: Condition aggravated, Impetigo, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Worsening spondyloarthritis and fibromyalgia symptoms, persistent impetigo infection.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Survey response — day 42, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: FairFree text: Fibromyalgia and spondyloarthritis flareups, but likely due to seasonalityMedDRA releases: 2024-11 · check-in free text available
-
2022-02-23
Survey response — 3 months, dose 2MedDRA: Condition aggravated, Pre-existing disease, Stress — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Work and personal stress induced flareups of existing conditions (fibromyalgia, spondyloarthritis).MedDRA releases: 2024-11 · check-in free text available
-
2022-05-26
Dose 3 — Moderna
-
2022-05-27
Survey response — days 1–6 daily, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Am also in the middle of severe flareup of fibromyalgia.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-27
Survey response — 6 months, dose 2MedDRA: Peripheral spondyloarthritis, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Worsening fibro and spondyloarthritis from overwork.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolAdult check-in
-
2022-05-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-05-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2022-06-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolAdult check-in
-
2022-06-02
Health check-in — day 7, dose 3Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolAdult check-in
- 2022-06-09
- 2022-06-16
- 2022-06-23
- 2022-06-30
- 2022-07-07
-
2022-08-25
Survey response — 3 months, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Worsening fibromyalgia and spondyloarthritis symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-11-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-24 | Moderna | No |
| 3 | 2022-05-26 | Moderna | No |
Free text
Release 7 — day 14, dose 1
Symptoms: Worse symptoms for spoldyloarthritis, fibromyalgia, eczema triggering use of FMLA for 2 days. Suspect related to weather/pressure changes rather than vaccine.
Release 8 — day 28, single dose
Symptoms: Related to chronic conditions - spondyloarthritis and fibromyalgia - compounded with work stress. High joint pain and fatigue.
Release 8 — day 42, single dose
Symptoms: Related to chronic conditions (spondyloarthritis, fibromyalgia) and work stress, not related to vaccine.
Release 10 — day 0, dose 2
Systemic reaction (other): Slight lightheadedness not reaching the point of dizziness
Release 10 — day 14, dose 2
Symptoms: Infection on upper lip related to runny nose, have scheduled appointment.
Release 10 — day 21, dose 2
Symptoms: Fibromyalgia and spondyloarthritis flareup
Release 10 — day 28, dose 2
Symptoms: Impetigo infectionon upper lip, oncycholysis in 3 toenails. I am immunosuppressed with a history of thyroid issues so it is likely just a result of these preexisting conditions.
Release 10 — day 35, dose 2
Symptoms: Worsening spondyloarthritis and fibromyalgia symptoms, persistent impetigo infection.
Release 10 — day 42, dose 2
Symptoms: Fibromyalgia and spondyloarthritis flareups, but likely due to seasonality
Release 11 — 3 months, dose 2
Symptoms: Work and personal stress induced flareups of existing conditions (fibromyalgia, spondyloarthritis).
Release 11 — 6 months, dose 2
Symptoms: Worsening fibro and spondyloarthritis from overwork.
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Am also in the middle of severe flareup of fibromyalgia.
Release 12 — 3 months, dose 3
Symptoms: Worsening fibromyalgia and spondyloarthritis symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Eczema | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Impaired work ability | ✓ | ✓ | ✓ |
| SD | Impetigo | · | · | ✓ |
| SD | Lip infection | · | · | ✓ |
| SD | Onycholysis | · | · | ✓ |
| SD | Peripheral spondyloarthritis | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sensitivity to weather change | ✓ | ✓ | ✓ |
| SD | Stress | · | · | ✓ |
| SD | Stress at work | ✓ | ✓ | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Condition aggravated | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release